Deferred Tax Assets and Other Non-Current Assets
ResMed Deferred Tax Assets and Other Non-Current Assets increased by 9.3% to $312.59M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 44.2%, from $216.80M to $312.59M. Over 4 years (FY 2021 to FY 2025), Deferred Tax Assets and Other Non-Current Assets shows an upward trend with a 156.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase generally suggests the accumulation of long-term economic benefits or tax recovery potential.
Detailed definition
This is the aggregate balance of non-current deferred tax assets and other miscellaneous non-current assets that do not...
Peer comparison
Varies widely based on the specific composition of 'other' assets, making it a general indicator of long-term asset health.
deferred_tax_assets_other_noncurrentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$5.85M | $80.77M | $74.67M | $74.84M | $79.75M | $80.75M | $85.78M | $95.60M | $132.97M | $138.27M | $155.96M | $162.11M | $203.57M | $220.53M | $209.45M | $216.80M | $253.12M | $275.95M | $285.91M | $312.59M |
| QoQ Change | — | >999% | -7.5% | +0.2% | +6.6% | +1.3% | +6.2% | +11.4% | +39.1% | +4.0% | +12.8% | +3.9% | +25.6% | +8.3% | -5.0% | +3.5% | +16.8% | +9.0% | +3.6% | +9.3% |
| YoY Change | — | — | — | — | >999% | -0.0% | +14.9% | +27.7% | +66.7% | +71.2% | +81.8% | +69.6% | +53.1% | +59.5% | +34.3% | +33.7% | +24.3% | +25.1% | +36.5% | +44.2% |
Deferred Tax Assets and Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is ResMed's deferred tax assets and other non-current assets?
- ResMed (RMD) reported deferred tax assets and other non-current assets of $312.59M in Q1 2026.
- How has ResMed's deferred tax assets and other non-current assets changed year-over-year?
- ResMed's deferred tax assets and other non-current assets increased by 44.2% year-over-year, from $216.80M to $312.59M.
- What is the long-term trend for ResMed's deferred tax assets and other non-current assets?
- Over 4 years (2021 to 2025), ResMed's deferred tax assets and other non-current assets has grown at a 156.5% compound annual growth rate (CAGR), from -$5.85M to $253.12M.
- What does deferred tax assets and other non-current assets mean?
- The combined value of long-term tax assets and other miscellaneous long-term assets.